Nanophase announces supply agreement with Roche Diagnostics through 2014

By Elaine Rigoli

Tampa, Fla., March 6 - Nanophase Technologies announced a new supply agreement with Roche Diagnostics to supply certain nanoparticles for a medical diagnostics application through 2014.

Additional material terms of the agreement were not disclosed.

"We are obviously pleased with this long-term supply agreement with Roche Diagnostics and look forward to growth in the product line and potential new collaboration with Roche," Ian Roberts, Nanophase's vice president of U.S. and international sales, said in a company statement.

"This is yet another product where Nanophase's innovative technologies produce nanomaterials that offer unique performance attributes for optimal application performance."

Romeoville, Ill.-based Nanophase provides nanoengineered solutions for multiple industrial product applications.

Roche Diagnostics is a global health care company with corporate headquarters in Basel, Switzerland.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.